MariMed Inc.
MRMD
$0.1066
$0.00414.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.62% | 10.73% | 10.33% | 8.57% | 14.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.62% | 10.73% | 10.33% | 8.57% | 14.41% |
| Cost of Revenue | 8.43% | 16.81% | 13.00% | 7.81% | 23.74% |
| Gross Profit | -0.36% | 3.25% | 7.04% | 9.52% | 4.17% |
| SG&A Expenses | 11.49% | 25.79% | 42.77% | 17.37% | 31.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.60% | 20.23% | 23.31% | 11.52% | 26.55% |
| Operating Income | -48.53% | -67.12% | -60.47% | -22.01% | -43.46% |
| Income Before Tax | -276.17% | -176.38% | -78.24% | -449.55% | -96.29% |
| Income Tax Expenses | -85.32% | -55.52% | -32.21% | 125.45% | 79.63% |
| Earnings from Continuing Operations | 76.69% | -75.29% | -94.58% | -313.23% | -256.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -260.00% | 47.83% | -131.58% | -650.00% | 162.50% |
| Net Income | 76.26% | -72.34% | -101.24% | -314.04% | -257.39% |
| EBIT | -48.53% | -67.12% | -60.47% | -22.01% | -43.46% |
| EBITDA | -23.67% | -31.43% | -35.69% | 10.34% | -20.29% |
| EPS Basic | 76.32% | -62.96% | -84.21% | -292.86% | -242.50% |
| Normalized Basic EPS | -100.00% | -129.17% | -81.48% | -71.70% | -84.62% |
| EPS Diluted | 76.32% | -62.96% | -84.21% | -292.86% | -242.50% |
| Normalized Diluted EPS | -100.00% | -129.17% | -81.48% | -68.09% | -82.61% |
| Average Basic Shares Outstanding | 2.02% | 5.05% | 9.46% | 10.77% | 10.05% |
| Average Diluted Shares Outstanding | 2.02% | 5.05% | 9.46% | -1.53% | -2.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2.95% | -- | -- | -- | -1.36% |
